Market Tracker

06/27 7:08am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.55
Delayed Data
As of Jun 24
 +0.10 / +6.90%
Today’s Change
1.08
Today|||52-Week Range
3.33
-5.49%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.45
Today’s open1.30
Day’s range1.30 - 1.55
Volume100,374
Average volume (3 months)121,194
Market cap$44.9M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+8.52%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
ERBERBA Diagnostics Inc+0.01+1.12%
CGIXCancer Genetics Inc-0.02-0.98%
TROVUTrovagene Inc0.000.00%
TTHITransition Therapeut...-0.06-7.27%
Data as of 06/24/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts